NovaBridge Biosciences CEO, director Srishti Gupta files initial beneficial ownership statement

NovaBridge Biosciences filed a Form 3 naming Srishti Gupta as chief executive officer, disclosing her initial insider holdings as of July 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002024011-26-000004), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

NovaBridge Biosciences filed a Form 3 with the SEC, disclosing that CEO and Director Srishti Gupta holds initial beneficial ownership as of July 1, 2026. The filing was published via EDGAR on July 8, 2026.

NovaBridge Biosciences filed a Form 3 naming Srishti Gupta as chief executive officer, disclosing her initial insider holdings as of July 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002024011-26-000004), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here